Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02211820 · ClinicalTrials.gov registry record

PET Imaging in Chronic Traumatic Encephalopathy

A clinical trial, sponsored by National Institute of Mental Health (NIMH).

Completed
Registry status
6
Enrollment target

NCT02211820 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 6 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02211820 has completed, sponsored by National Institute of Mental Health (NIMH).

COMPLETED
Registry status
6 participants
Enrollment target

Study Summary

Background: \- Chronic traumatic encephalopathy (CTE) is a brain disease caused in part by head injury. The brain changes from CTE can only be seen at autopsy. Researchers want to test a new brain scan to help diagnose CTE in living patients. Objective: \- To determine if a new type of brain scan can detect changes that occur in chronic traumatic encephalopathy. Eligibility: \- Adults age 18 60 with previous head injury or participation in certain sports. Design: * Participants will be screened with: * Physical exam * Blood and urine tests * Tests of thinking, mood, and memory * 30-minute magnetic resonance imaging (MRI) brain scan. A magnetic field and radio waves take pictures of the brain. Participants will lie on a table that slides into a metal cylinder. They will get earplugs for the loud knocking sounds. * Visit 1: Participants will have a 70-minute PET scan of the brain with a small amount of a radioactive chemical. That will be injected through an intravenous tube (catheter) in each arm. A catheter will also be put into an artery at the wrist or elbow. * Participants will lie on a bed that slides in and out of a donut-shaped scanner. A plastic mask may be molded to their face and head. Vital signs and heart activity will be checked before and during the scan. * Blood and urine will be taken before and after the scan. * Participants will be checked on by phone the next day. * Visit 2: Participants will repeat Visit 1 with a different chemical and no artery catheter. * Visit 3: Participants may have a spinal tap. Some fluid will be removed by needle between the bones in the back.

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2014-08-01
Est. Completion 2016-10-12

What the Registry Record Tells You About NCT02211820

The ClinicalTrials.gov registry entry for NCT02211820 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02211820 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02211820 about?

NCT02211820 is a clinical study titled "PET Imaging in Chronic Traumatic Encephalopathy". Background: \- Chronic traumatic encephalopathy (CTE) is a brain disease caused in part by head injury. The brain changes from CTE can only be seen at autopsy. Researchers want to test a new brain scan to help diagnose CTE in living patients. Objective: \- To determine if a new type of brain scan...

What is the current status of trial NCT02211820?

This trial is currently completed. The enrollment target is 6 participants. The study started on 2014-08-01. Estimated completion is 2016-10-12.

Who is sponsoring clinical trial NCT02211820?

This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.